Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Endometrial Neoplasms 5Ovarian Neoplasms 4Sarcoma 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Endometrial Stromal 1Recurrence 1Primary Myelofibrosis 1Neurofibrosarcoma 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leiomyosarcoma 1Genital Diseases 1Fallopian Tube Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Doxorubicin 5Ifosfamide 3Filgrastim 3belinostat 2Nivolumab 2Imatinib Mesylate 2Gemcitabine 2Docetaxel 2selinexor 1saracatinib 1rucaparib 1perifosine 1pembrolizumab 1brostallicin 1Vorinostat 1Trabectedin 1Therapeutics 1Temozolomide 1Sunitinib 1Radiotherapy 1Radiation, Ionizing 1Mass Spectrometry 1Letrozole 1Injections 1Fluorouracil 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × selinexor × Gynecologic × Clear all
NCT04811196 2025-05-29

A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients

University Health Network, Toronto

Phase 1 Completed
56 enrolled
GynecologicSarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡